17.15
Tossidromi: Caratteristiche cliniche
I tossidromi sono quadri sintomatici specifici derivanti dall'esposizione a sostanze tossiche. Contribuiscono all'identificazione e al trattamento del…
I tossiromi sono schemi sintomatici distinti che segnalano un'overdose di farmaco o sostanze chimiche. Il loro riconoscimento consente una diagnosi e un trattamento rapidi.
I tossidomi più comuni sono anticolinergici, colinergici, oppioidi, simpaticomimici, sedativi e ipnotici.
Il toxidromo anticolinergico deriva dall'inibizione dei recettori muscarinici e dalla soppressione parasimpatica che provocano pelle secca e arrossata, ipertermia, midriasi, delirio e ridotta motilità intestinale.
Gli agenti colinergici inibiscono l'acetilcolinesterasi, causando accumulo di acetilcolina e sovrastimolazione muscarinica.
Il toxidromo colinergico causa sonnolenza, coma, miosi, salivazione eccessiva, diarrea, crampi gastrici, vomitosi e spasmi muscolari.
L'overdose da oppioidi sopprime il SNC, causando tipicamente miosi, depressione respiratoria, bradicardia e ridotta motilità intestinale.
Successivamente, il tossiromo simpaticomitico deriva dalla stimolazione simpatica, portando a agitazione, ipertensione, tachicardia, midriasi, tremori, sudorazione e ipertermia.
Sedativi e ipnotici causano sonnolenza, depressione respiratoria e riflessi diminuiti.
View the full transcript and gain access to JoVE Core videos
Q1: What are toxidromes and why do healthcare providers need to recognize them?
Toxidromes are distinct symptom patterns that signal drug or chemical overdose, enabling rapid diagnosis and treatment. Recognition of these patterns is critical for healthcare providers to manage poisoning effectively and initiate appropriate pharmaceutical poisoning treatment strategies quickly.
Q2: What causes anticholinergic toxidrome and what are its clinical features?
Anticholinergic toxidrome results from muscarinic receptor inhibition and parasympathetic suppression. Clinical features include dry flushed skin, hyperthermia, mydriasis (dilated pupils), delirium, and reduced intestinal motility. Drugs like atropine and diphenhydramine commonly cause this pattern.
Q3: How does cholinergic toxidrome develop and what symptoms does it produce?
Cholinergic toxidrome occurs when agents inhibit acetylcholinesterase, causing acetylcholine accumulation and muscarinic overstimulation. Symptoms include somnolence, coma, miosis (constricted pupils), excessive salivation, diarrhea, gastric cramping, emesis, and muscle twitching. Organophosphates are a common cause.
Q4: What distinguishes sympathomimetic toxidrome from other toxidromes?
Sympathomimetic toxidrome results from sympathetic nervous system stimulation, producing agitation, hypertension, tachycardia, mydriasis, tremors, sweating, and hyperthermia. Cocaine and amphetamines commonly cause this pattern, which contrasts with depressant toxidromes that reduce vital signs.
Q5: What respiratory and cardiovascular effects characterize opioid overdose?
Opioid overdose suppresses the central nervous system, typically causing miosis, respiratory depression, bradycardia, and reduced gut motility. These effects result from opioid receptor activation and can rapidly become life-threatening if not treated promptly.
Q6: How do sedative and hypnotic toxidromes affect the central nervous system?
Sedatives and hypnotics depress central nervous system activity, causing drowsiness, respiratory depression, and diminished reflexes. Benzodiazepines and barbiturates are common examples that produce this depressant toxidrome pattern affecting multiple organ systems.
Q7: What are the six most common toxidromes encountered in clinical practice?
The six most common toxidromes are anticholinergic, cholinergic, opioid, sympathomimetic, sedative-hypnotic, and salicylate. Each produces a distinct symptom cluster reflecting the drug class's mechanism of action on the nervous system and vital functions.